Programme of 6th Excellence Course for Oncology Pharmacy
Venue: Netcare Head Office, 76 Maud street Cnr West, Sandton Johannesburg
14 May – 18 May 2025 (Wednesday till Sunday)
Wednesday, 14 May 2025
08.00 – 08.15
Johan Labuschagne (SASOPh Chair) Carien vd Merwe (SASOPh Board):
Opening / Introduction
08.15 – 08.30
Klaus Meier (ESOP Chair):
Christophe Bardin (EUSOP Chair):
Welcome
(*1.C.1)
8.30 – 09.30
Gregers Chalker:
Aseptic Technique, Facilities, Room design and HVAC
(*2.B)
9.30 – 10.30
Teresa Smit:
Clinical Trials in Oncology
(*2.B)
10.30 – 11.00
Coffee Break
11.00 – 12.00
Sherif Kamal:
Medication use Process: quality management
(*1.C.1)
12.00 – 13.00
Lunch
15.00 – 15.30
Coffee Break
15.30 – 17.00
Dr Christophe Bardin:
Prescription check and Methods of Dose Calculation
(*1.C.6 / 1.C.7)
17.000 – 17.30
Dr Christophe Bardin:
Pharmaceutical Intervention in Emergency Oncology
(*2.J)
17.30 – 18.30
The risk of working with cytotoxic drugs and monitoring methods in occupational health EEP
(*1.F.1/ 1.F.2)
Thursday, 15 May 2025
08.00 – 09.00
Dr Christophe Bardin:
Interactions of Anticancer Drugs (including CAM)
(*3.G)
09.00 – 10.00
Sherif Kamal:
Psycho-Oncology
(*3.K)
10.00 – 10.30
Coffee Break
10.30 – 12.00
Sherif Kamal:
Patient Counselling/ practical
(*3.J.1)
12.00 – 13.00
Dr Christophe Bardin:
Introducing Biologics in cancer
(*4.A.3)
13.00 – 14.00
Lunch
14.00 – 15.00
Dr Christophe Bardin:
Substitution/ Interchangeability/Switching/ Extrapolation between clinical indication
(*4.D.2/ 4.D.5)
15.00 – 16.00
Prof. Georgia Demetriou:
Breast Cancer
[*2.D/4.F.4/ 4.F.6]
16.30 – 16.30
Razeeya Khan:
Clinical case on Breast Cancer
[*2.D/4.F.4/ 4.F.6]
16.30 – 17.00
Coffee Break
17.00 – 18.00
Dr Christophe Bardin:
Side Effects of Anticancer Drugs EEP
[*3.H]
Social Function
Friday, 16 May 2025
09.00 – 10.00
Prof Lydia Dreosti:
Head/ Neck Cancers
(*3.L.6)
10.00 – 10.30
Coffee Break
10.30 – 12.30
Devices, Clean working and Waste Disposal practical
(*1.D.1 / 1.C.2 / 1.C.5)
12.30 – 13.30
Lunch
13.30 – 14.30
Dr Christophe Bardin:
Physiochemical stability of anticancer drugs/ Concerns and economics EEP
[*2.D/4.F.4/6]
14.30 – 15.00
Coffee Break
15.00 -16.00
Dr Thandiswe Lusu:
Gynaecological cancers
(*3.L.2)
16.00 – 16.30
Mrs Antje Viljoen:
Clinical case on Gynaecological cancers
16.30 – 18.00
Dr Adam Nosworthy:
Digestive Cancers
(*3.L.1)
18.00 – 18.30
Hayley Gower:
Clinical case on digestive cancers
Saturday, 17 May 2025
08.30 – 10.00
Prof Paul Ruff:
Systemic therapy of malignant disease including chemotherapy and biological therapy
[*1.B.1]
10.00 – 10.30
Coffee Break
10.30 – 11.30
Prof Bernado Rapoport:
Urological Cancers (Prostate Cancer)
(*3.L.3)
11.30 – 12.00
Evah Lediga:
Clinical case on Prostate cancers
12.00 – 13.00
Dr Michael Cass:
Immunotherapy: pharmacology and clinical use EEP
13.00 – 14.00
Lunch
14.00 – 15.30
Dr Philippa Ashmore:
Haematological malignancies
(*3.L.5)
15.30 – 16.00
Johandre van Jaarsveld:
Clinical case on Haematological malignancies
16.00 – 16.30
Coffee Break
16.30 – 17.30
Prof Moosa Patel:
HIV and related cancers (Kaposi Sarcoma) EEP
Sunday, 18 May 2025
08.00 – 09.00
Prof Jennifer Geel:
Treatment of Paediatric Oncology Patients
[*3.M]
09.00 – 09.30
Tegan Bilse:
Clinical case on Paediatric cancers
(*3.L.3)
09.30 – 10.00
Coffee Break
10.00-11.00
Dr Karishma Singh:
Lung Cancer
(*3.L.7)
11.00 – 11.30
Quinton Barber:
Clinical case on Lung cancer
11.30 – 12.30
Dr Jason Naicker:
Melanoma and non-melanoma skin cancers
(*3.L.4)
12.30 – 13.30
Lunch
13.30 – 14.30
Dr David Britain:
Stem Cell Transplantation and CAR-T therapy – /ATMPS EEP
14.30 – 16.00
Dr Christophe Bardin:
Closing and handing over of certificates
*EEP : Extra ExCOP Program